MALIGNANT TRANSFORMATION side effect
What is MALIGNANT TRANSFORMATION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
MALIGNANT TRANSFORMATION and Recently Reported Side Effects
MALIGNANT TRANSFORMATION and 15 most Active Side Effect polls
MALIGNANT TRANSFORMATION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Revlimid Side Effects Report #5481954-1
Physician from UNITED STATES reported REVLIMID problem on Sept 26, 2007. Male patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, malignant transformation, myelodysplastic syndrome, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 07/18/2006.
Revlimid Side Effects Report #5486214-0
REVLIMID problem was reported by a Physician from UNITED STATES on Oct 08, 2007. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute leukaemia, malignant transformation, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 06/26/2007.
Tamoxifen Side Effects Report #5747250-X
Consumer or non-health professional from FRANCE reported TAMOXIFEN CITRATE problem on May 05, 2008. Female patient, 66 years of age, was treated with TAMOXIFEN CITRATE. After drug was administered, patient experienced the following problems/side effects: endometrial cancer, malignant transformation, . TAMOXIFEN CITRATE dosage: unknown. Patient recovered.
Tamoxifen Side Effects Report #5753039-8
TAMOXIFEN CITRATE problem was reported by a Consumer or non-health professional from FRANCE on May 15, 2008. Female patient, 66 years of age, was treated with TAMOXIFEN CITRATE. After drug was administered, patient experienced the following problems/side effects: endometrial cancer, malignant transformation, . TAMOXIFEN CITRATE dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5483620-5
Physician from UNITED STATES reported REVLIMID problem on Sept 27, 2007. Female patient, 55 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, disease progression, malignant transformation, myelodysplastic syndrome, pneumonia fungal, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 08/24/2007.